Literature DB >> 8982615

Trends of the characteristics and appropriateness of admissions to acute geriatric and medical wards in Italy from 1988 through 1993. Gruppo Italiano di Farmacovigilanza nell'Anziano--GIFA.

M Pahor1, L Carosella, C Pedone, A Manto, P Carbonin.   

Abstract

Recent modifications in the health care system in Italy reduced the number of inpatient care beds and limited the access to outpatient services while the proportion of older persons increased. To assess the burden of these changes on hospital care the characteristics of admissions to 35 acute geriatric wards and 31 internal medicine wards in Italy were studied between 1988 and 1993. All patients admitted during 4 months in 1988, 1 month in 1991 and 4 months in 1993 were enrolled in the study. The appropriateness of admission was assessed by means of the Appropriateness Evaluation Protocol criteria. The Charlson comorbidity index score was used to quantify comorbidity. Between 1988 and 1993, 18,790 patients were studied. The mean age increased from 67.9 +/- 0.2 to 71.7 +/- 0.2 years (p < 0.0001), the mean number of drugs taken during hospital stay increased from 5.2 +/- 0.0 to 5.5 +/- 0.0 drugs (p < 0.0001), the mean Charlson comorbidity index score increased from 1.33 +/- 0.02 to 1.50 +/- 0.03 (p < 0.0001) and the mean length of stay decreased from 17.6 +/- 0.2 to 16.1 +/- 0.2 days (p < 0.0001). The rate of appropriate admissions increased from 68.6% to 85.5% (p < 0.0001). Consistent results were found when the data were stratified according to gender and type of ward. It was concluded that in Italy, concurrently to an increased load of hospital care, inappropriate admissions diminished over time. These data show that the need for geriatric care is increasing.

Entities:  

Mesh:

Year:  1996        PMID: 8982615     DOI: 10.1007/bf00499454

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  12 in total

1.  Aging of the population: demographic and social changes.

Authors:  A Golini; A Lori
Journal:  Aging (Milano)       Date:  1990-12

2.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Authors:  R A Deyo; D C Cherkin; M A Ciol
Journal:  J Clin Epidemiol       Date:  1992-06       Impact factor: 6.437

3.  Hospital use and mortality among Medicare beneficiaries in Boston and New Haven.

Authors:  J E Wennberg; J L Freeman; R M Shelton; T A Bubolz
Journal:  N Engl J Med       Date:  1989-10-26       Impact factor: 91.245

4.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

5.  Drug data coding and analysis in epidemiologic studies.

Authors:  M Pahor; E A Chrischilles; J M Guralnik; S L Brown; R B Wallace; P Carbonin
Journal:  Eur J Epidemiol       Date:  1994-08       Impact factor: 8.082

6.  Hospital readmission rates for cohorts of Medicare beneficiaries in Boston and New Haven.

Authors:  E S Fisher; J E Wennberg; T A Stukel; S M Sharp
Journal:  N Engl J Med       Date:  1994-10-13       Impact factor: 91.245

7.  A comparative analysis of appropriateness of hospital use.

Authors:  J D Restuccia; P Gertman
Journal:  Health Aff (Millwood)       Date:  1984       Impact factor: 6.301

8.  Longer life but worsening health? Trends in health and mortality of middle-aged and older persons.

Authors:  L M Verbrugge
Journal:  Milbank Mem Fund Q Health Soc       Date:  1984

9.  The impact of age on risk of adverse drug reactions to digoxin. For The Gruppo Italiano di Farmacovigilanza nell' Anziano.

Authors:  M Pahor; J M Guralnik; G Gambassi; R Bernabei; L Carosella; P Carbonin
Journal:  J Clin Epidemiol       Date:  1993-11       Impact factor: 6.437

10.  Is age an independent risk factor of adverse drug reactions in hospitalized medical patients?

Authors:  P Carbonin; M Pahor; R Bernabei; A Sgadari
Journal:  J Am Geriatr Soc       Date:  1991-11       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.